2010 KEYWORDS ABSTRACT INTRODUCTION

AppNote 8/2010 Stir Bar Sorptive Extraction (SBSE) and GC/MS Determination of Polar and Non-polar Drugs and Pharmaceuticals in Post Mortem Brain Tiss...
Author: Francis Booth
2 downloads 1 Views 890KB Size
AppNote 8/2010

Stir Bar Sorptive Extraction (SBSE) and GC/MS Determination of Polar and Non-polar Drugs and Pharmaceuticals in Post Mortem Brain Tissue Oliver Lerch, Susanne Sperling Gerstel GmbH & Co. KG, Eberhard-Gerstel-Platz 1, D-45473 Mülheim an der Ruhr, Germany

KEYWORDS Drugs of abuse, Pharmaceuticals, Tissue samples, Stir Bar Sorptive Extraction (SBSE), Thermal Desorption Unit (TDU)

ABSTRACT Stir Bar Sorptive Extraction (SBSE) is an innovative and efficient method [1] for the extraction of drugs and pharmaceuticals from blood-, urine- and tissue samples in a forensic toxicology laboratory. As shown in this application note and earlier publications [2,3,4], SBSE is an effective screening tool for drugs and pharmaceuticals in biological fluids and tissue. The SBSE technique is easy to use and the method described in this publication is performed without additional use of organic solvents, centrifugation, or the liquid transfer steps that are normally necessary when performing liquid-liquid or solid-phase extraction.

INTRODUCTION GC/MS determination of pharmaceutical compounds and drugs in biological samples is usually done by isolating the compounds of interest and/or their metabolites from the biological matrix. The sample preparation techniques most often used in routine analysis are based on liquid-liquid extraction, protein precipitation and solid-phase extraction (SPE). The main drawback of these methods is that they are labor intensive and involve working with toxic organic solvents. The SBSE technique using the GERSTEL Twister

was developed to extract organic components from an aqueous matrix practically without any sample preparation. The Twister is a glass-encased magnetic stir bar coated with an extraction phase of polydimethylsiloxane (PDMS). When the Twister stirs an aqueous sample or an aqueous slurry of a solid sample it extracts analytes into the PDMS phase. Just as in liquid-liquid extractions, analytes partition between the extractant phase, in this case PDMS, and the liquid sample phase. Following their extraction, analytes can be transferred to a GC system by thermally desorbing the Twister or to an LC system by re-extracting the Twister with an LC-compatible solvent. Derivatization of the analytes can alternatively be performed directly on the Twister or during the thermal desorption process by adding a derivatization agent to the carrier gas. This would be done using a derivatization pneumatic accessory installed on the thermal desorption instrument. In this application work, the GERSTEL Twister was used to extract target analytes with different chemical properties from bovine brain and liver tissue for subsequent GC/MS determination. Basic, acidic and neutral compounds were included in a positive control mix suggested by the German Society of Toxicological and Forensic Chemistry (GTFCh, Table 1). Furthermore an extraction and screening for unknown substances in bovine brain and liver tissue was conducted during a GTFCh workshop. In order to determine the presence of drugs of abuse in forensic samples it is mandatory that the extraction medium be absolutely free from compounds of interest. Used Twisters are cleaned and conditioned by washing them for hours in acetonitrile or methanol/

dichloromethane 1/1 followed by thermal desorption overnight at 300 °C under a flow of nitrogen. Before adding the Twister to a sample, a blank run of the Twister should by performed and the background checked to ensure that the Twister doesn’t contain background levels of any compounds of interest. Table 1. Analytes included in the positive control standard used (GTFCh mix). Analyte

Target Ion [m/z]

Qual. Ions [m/z]

Conc. [ng/g]

Amphetamine 4.601

44

91/65

500

Salicylic Acid

6.160

120

92/138/64

5000

Ibuprofen

9.580

161

163/206/119

5000

Paracetamol

10.558

109

151/80/108

5000

Phenobarbital 13.646

204

117/115/103

5000

Metoprolol

14.359

72

107/223

500

Methadone

15.525

72

57/165

500

Cocaine

16.093

182

82/94/77

500

Doxepin

16.154

58

42/165

500

Codeine

17.827

299

162/214

500

Diazepam

18.329

256

258/284/257

500

THC

18.486

299

314/231/271

100

Morphine

18.246

285

162/215/115

500

THC-COOH

RT [min]

50

Figure 1. The GERSTEL Twister, used for stir bar sorptive extraction of drugs and pharmaceuticals from brain tissue in the work reported here. AN/2010/8 - 2

EXPERIMENTAL Materials. 0.1 M Trizma buffer solution pH 8.5 saturated with NaCl (Sigma Aldrich), PDMS Twister (2 cm lenght, 1 mm phase thickness, GERSTEL). Instrumentation. Tissue was homogenized using an IKA® Ultra Turrax® Tube Drive. The analyses were performed using a 6890N GC equipped with a 5975 (inert XL Triple Axis) Mass Selelective Detector (Agilent Technologies), a Thermal Desorption Unit (TDU), Cooled Injection System (CIS 4) and Multi Purpose Sampler (MPS) (all GERSTEL). Analysis Conditions TDU: Temperature 50°C; 300°C/min; 280°C (10 min) Pneumatics Splitless CIS 4: Temperature -100°C; 2°C/s; 300°C (26 min) Pneumatics Solvent Vent @ 3 min, 50 mL/min Liner Quartz wool deactivated, 2 mm GC: Temperature 100°C (1 min); 10°C/min; 325°C (6.5 min) Pneumatics He, 111.4 kPa, constant pressure Retention Time Locked (RTL) with Proadifen (SKF 525-A) Column Rxi-5ms 30 m di = 0.25 mm df = 0.25 μm Detector: MSD EI mode, scan, 40-570 amu

Sample Preparation - A 2 g sample of spiked tissue was homogenized for 10 minutes using the IKA® Ultra Turrax® Tube Drive - 1 g of the tissue homogenate was transferred to a 25 mL vial using a 5 mL Eppendorf Pipette - 5 mL of Trizma buffer pH 8.5 saturated with NaCl was added - A conditioned Twister was added and the vial was capped - The sample was extracted for 3 h on a magnetic stirring plate at 1000 rpm (For the positive control mix 0.5 h extraction time is sufficient, but when screening for unknown compounds, the extraction time should be extended) - After the extraction. the Twister was carefully removed, rinsed with deionized water, dried with a lint-free paper tissue, and placed in a thermal desorption tube which was in turn placed in the autosampler tray.

RESULTS AND DISCUSSION The Twister (SBSE) extraction method was chosen for screening of drugs and pharmaceuticals since the SBSE process is simpler and less labor intensive than traditional methods, and since it is solvent free. For routine analysis of large series of samples, the GERSTEL MultiPurpose Sampler (MPS) enables automated processing of up to 196 Twisters in one batch. The evaluation of the chromatogram of the positive control standard (GTFCh mix) was done using a target database in the Agilent MSD Chemstation Software. In the chromatogram shown in figure 2, the annotated peaks represent those analytes that could be extracted from the positive control mix. Only a few highly polar (e.g. salicylic acid) or GC-incompatible compounds (THC-COOH) could not be found.

AN/2010/8 - 3

Cholesterol

2.6e+07

Methadone

2.5e+07 2.4e+07

2.3e+07 2.2e+07

Doxepin

2.1e+07 2e+07 1.9e+07 1.8e+07

1.7e+07 1.6e+07

Diazepam

1.5e+07

Cocaine

1.4e+07 1.3e+07 1.2e+07 1.1e+07 1e+07 9000000 8000000

4000000 3000000 2000000 1000000 9.0

10.00

11.00

12.00

13.00

14.00

15.00

16.00

17.00

18.00

THC

Ibuprofen

5000000

Codeine

Phenobarbital

6000000

Metoprolol

7000000

19.00

20.00

21.00

22.00

23.00

Figure 2. Chromatogram of positive control (GTFCh mix) extracted with GERSTEL twister from bovine brain tissue. Labeled analytes were identified. When screening a large number of samples for unknown compounds, the analyst needs an efficient way to search for non-target substances in MSD-chromatograms. A useful tool for the task is the Agilent Deconvolution Reporting Software (DRS) which can be started from the Agilent MSD ChemStation. DRS performs a deconvolution of the chromatogram based on AMDIS Software (Automated Mass Spectral Deconvolution and Identification System) combined with library searches (> 700 substances) based on the deconvoluted spectra. Not only the mass spectrum of a compound, but also the retention time is used as identification criterion (figure 3). The retention time of each analyte from the library is adjusted to the retention time stored in the library using Retention Time Locking (RTL) prior to analysis. For this purpose, one locking compound needs to be determined at different carrier gas pressures. From these results, the “correct” pressure for the actual column is determined in order to determine the exact retention times for all compounds in the library. For each spectrum found in the AMDIS deconvolution process, the matching compound is searched in the NIST08 library. Furthermore all known substances can be searched in the chromatogram in the MSD ChemStation via a target library that is based on the substances in the AMDIS Figure 3. Screenshot of AMDIS (Automated Mass Spectral Deconvolution and database. Identification System) software. AN/2010/8 - 4

Following the different library searches, the results are automatically summarized in a report. After a diligent check of the report, the final analysis results can be determined. The described method was used during a GTFCh workshop held in Düsseldorf, Germany, in 2010. Clomethiazole, phenprocoumon, papaverine and noscapine were found and identified in unknown brain and liver samples (figure 5, 7). Also xylazine was found in the brain sample, probably an artifact since it used as a sedative, for example, to help calm cattle during transport. Therefore it is probably found directly in the bovine brain sample and is not one of the spiked unknowns that should be found in the samples. The extracts appear to be quite clean. In the chromatograms of brain samples only a very low fatty acid background is seen. (figure 4). Even the liver samples, which have high fat content, yield acceptable full scan chromatograms (figure 6). Cholesterol

1.05e+08 1e+08

Clomethiazole

9.5e+07 9e+07 8.5e+07 8e+07 7.5e+07 7e+07 6.5e+07

5e+07 4.5e+07 4e+07 3.5e+07 3e+07

Octadecanoic acid

Hexadecanoic acid

6e+07 5.5e+07

2.5e+07 2e+07 1.5e+07 1e+07 5000000 6.00

8.00

10.00

12.00

14.00

16.00

18.00

22.00

20.00

Papaverine, m/z 338

Figure 4. Chromatogram of a Twister extract of a brain sample, full scan. 120000

70000

60000

50000

40000

Noscapine, m/z 220

80000

Phenprocoumon, m/z 251

90000

Xylazine, m/z 205

100000

Clomethiazole, m/z 112

110000

30000

20000

10000

6.00

8.00

10.00

12.00

14.00

16.00

18.00

20.00

22.00

Figure 5. Chromatogram of a Twister extract of a brain sample, extracted ion chromatograms. AN/2010/8 - 5

Hexadecanoic acid

1.6e+08 1.5e+08

Tetradecanoic acid

1.4e+08

1.1e+08 1e+08

9,12 Octadecadienoic acid

1.2e+08

Clomethiazole

1.3e+08

Cholesterol

1.7e+08

9e+07 8e+07 7e+07 6e+07 5e+07 4e+07

3e+07 2e+07 1e+07

6.00

8.00

10.00

12.00

14.00

16.00

18.00

20.00

22.00

200000

180000

160000

Papaverine, m/z 338

220000

Clomethiazole, m/z 112

Figure 6. Chromatogram of a Twister extract of a liver sample, full scan.

140000

100000

80000

60000

40000

Noscapine, m/z 220

Phenprocoumon, m/z 251

120000

20000

6.00

8.00

10.00

12.00

14.00

16.00

18.00

20.00

22.00

Figure 7. Chromatogram of a Twister extract of a liver sample, extracted ion chromatograms.

The analysis provides good repeatability as can be seen by comparing the two repeat analyses of spiked brain tissue shown in figure 8.

AN/2010/8 - 6

6000000

Phenprocoumon, m/z 251

35000

Clomethiazole, m/z 163

5500000 5000000 4500000 4000000 3500000 3000000 2500000 2000000 1500000

30000 25000 20000 15000 10000

1000000

5000

500000 16.50

2.50 3.00 3.50 4.00 4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00

Papaverine, m/z 338

90000 80000 70000 60000 50000 40000 30000

17.50

20000 10000 20.20 20.40 20.60 20.80 21.00 21.20 21.40 21.60 21.80 22.00 22.20 22.40

18.00

18.50

19.00

Noscapine, m/z 220

110000 100000

17.00

17000 16000 15000 14000 13000 12000 11000 10000 9000 8000 7000 6000 5000 4000 3000 2000 1000

120000

22.00

22.50

23.00

23.50

Figure 8. Two separate extractions of drugs from brain tissue using the repeatability.

24.00

24.50

25.00

25.50

26.00

GERSTEL-Twister®

showing good

CONCLUSIONS

REFERENCES

Stir bar sorptive extraction (SBSE) using the GERSTEL Twister is a powerful tool for screening tissue for drugs of abuse and pharmaceuticals. Almost no sample preparation is needed and thermal desorption of the Twisters is performed automatically by the MPS autosampler. Screening for unknowns can be facilitated using Agilent Retention Time Locking (RTL) combined with the Deconvolution Reporting Software (DRS) and the AMDIS software. The chromatograms are surprisingly clean considering the very complex sample matrix. The method shows good repeatability which means that quantification should be possible.

[1] P. Sandra, E. Baltussen, F. David, A. Hoffmann: ”A Novel Extraction Technique for Aqueous Samples: Stir Bar Sorptive Extraction”, GERSTEL AppNote 1/2000 [2] J. Crifasi, M. Bruder, C. Long, K.J. Janssen: “Performance Evaluation of Thermal Desorption System (TDS) for Detection of Basic Drugs in Forensic Samples by GC–MS”, J. Anal. Tox. 30 (2006), 1-12 [3] A. Vendenin, V. Sovorkin, E. Kachur: ”Stir Bar Sorptive Extraction-Thermal DesorptionCapillary GC-MS applied for Analysis of Amphetamine Derivatives in Biological Fluids”, GERSTEL AppNote 7/2004 [4] E. Pfannkoch, J. Whitecavage, R. Bramlett: “Feasibility of Extraction and Quantitation of 9-Tetrahydrocannabinol in Body Fluids by Stir Bar Sorptive Extraction (SBSE) and GC/MS“, GERSTEL AppNote 6/2005

ACKNOWLEDGEMENTS The Authors would like to acknowledge the kind support of the following persons: Professor Thomas Daldrup, Ph.D. Oliver Temme, Ph.D. Gernot Brauers, Ph.D. and co-workers at the Department of Forensic Toxicology of the University Hospital Düsseldorf, Germany.

“For research use only. Not for use in diagnostic procedures.” The information provided for this product is intended for reference and research purposes only. GERSTEL offers no guarantee as to the quality and suitability of this data for your specific application. Information, descriptions and specifications in this publication are subject to change without notice.

AN/2010/8 - 7

GERSTEL GmbH & Co. KG Eberhard-Gerstel-Platz 1 45473 Mülheim an der Ruhr Germany +49 (0) 208 - 7 65 03-0 +49 (0) 208 - 7 65 03 33 [email protected] www.gerstel.com

GERSTEL Worldwide

GERSTEL LLP Level 25, North Tower One Raffles Quay Singapore 048583 +65 6622 5486 +65 6622 5999 [email protected] www.gerstel.com

GERSTEL Brasil Av. Pascoal da Rocha Falcão, 367 04785-000 São Paulo - SP Brasil +55 (11)5665-8931 +55 (11)5666-9084 [email protected] www.gerstel.com.br

GERSTEL K.K. 1-3-1 Nakane, Meguro-ku Tokyo 152-0031 SMBC Toritsudai Ekimae Bldg 4F Japan +81 3 5731 5321 +81 3 5731 5322 [email protected] www.gerstel.co.jp

D QM-SY ST IFIE RT

CE

GERSTEL AG Wassergrabe 27 CH-6210 Sursee Switzerland +41 (41) 9 21 97 23 +41 (41) 9 21 97 25 [email protected] www.gerstel.ch

EM

GERSTEL, Inc. 701 Digital Drive, Suite J Linthicum, MD 21090 USA +1 (410) 247 5885 +1 (410) 247 5887 [email protected] www.gerstelus.com

R

Information, descriptions and specifications in this Publication are subject to change without notice. GERSTEL, GRAPHPACK and TWISTER are registered trademarks of GERSTEL GmbH & Co. KG.

O 9001:20 0 FI C AT N O . 0 E

IS

CE

TI

08 86 D

ISO 9001

© Copyright by GERSTEL GmbH & Co. KG

Awarded for the active pursuit of environmental sustainability

Suggest Documents